CLAIM CARD
This synthesis maps 47 included sources on Senescence Effects across 9 outcome classes and 331 cross-study disagreements. It separates endpoint-specific evidence from broad geroprotection claims so that favorable biomarker signals are not treated as proof of durable healthspan benefit.
Evidence grade: exploratory
Contradiction status: none
Publication: ec49b21a-665d-471c-b2c4-8ab5a5943e34
Provenance: Derivation Web chain
Citation Support
source_1Murray 2025source_2Mielke 2025source_3Zumerle 2024source_4Mury 2025source_5Zhao 2024